Structure and property based design of factor Xa inhibitors: Pyrrolidin-2-ones with aminoindane and phenylpyrrolidine P4 motifs

RJ Young, C Adams, M Blows, D Brown… - Bioorganic & medicinal …, 2011 - Elsevier
The rational design, syntheses and evaluation of potent sulfonamidopyrrolidin-2-one-based
factor Xa inhibitors incorporating aminoindane and phenylpyrrolidine P4 motifs are …

Rational design, synthesis, and biological activity of benzoxazinones as novel factor Xa inhibitors

DA Dudley, AM Bunker, L Chi, WL Cody… - Journal of medicinal …, 2000 - ACS Publications
Inappropriate thrombus formation within blood vessels is the leading cause of mortality in
the industrialized world. Factor Xa (FXa) is a trypsin-like serine protease that plays a key role …

Biarylmethoxy isonipecotanilides as potent and selective inhibitors of blood coagulation factor Xa

G Lopopolo, F Fiorella, M de Candia, O Nicolotti… - European Journal of …, 2011 - Elsevier
New chloro-substituted biarylmethoxyphenyl piperidine-4-carboxamides were synthesized
and assayed in vitro as inhibitors of the blood coagulation enzymes factor Xa (fXa) and …

Synthesis, SAR and in vivo activity of novel thienopyridine sulfonamide pyrrolidinones as factor Xa inhibitors

MR Becker, WR Ewing, RS Davis, HW Pauls… - Bioorganic & medicinal …, 1999 - Elsevier
Thienopyridine sulfonamide pyrrolidinones were found to be potent and selective inhibitors
of the coagulation cascade enzyme factor Xa. SAR studies led to several compounds that …

Structure–activity relationships of potent and selective factor Xa inhibitors: benzimidazole derivatives with the side chain oriented to the prime site of factor Xa

H Ueno, S Katoh, K Yokota, J Hoshi, M Hayashi… - Bioorganic & medicinal …, 2004 - Elsevier
A series of benzimidazole derivatives with the side chain on the nitrogen atom oriented to
the prime site of factor Xa (FXa) were designed and synthesized. Compounds with …

Design, synthesis, and structure–activity and structure–pharmacokinetic relationship studies of novel [6, 6, 5] tricyclic fused oxazolidinones leading to the discovery of …

T Xue, S Ding, B Guo, Y Zhou, P Sun… - Journal of Medicinal …, 2014 - ACS Publications
The blood coagulation enzyme factor Xa (FXa) is a particularly promising target for
anticoagulant therapy, and identification of oral small-molecule inhibitors of FXa remains a …

1-(2-Naphthyl)-1H-pyrazole-5-carboxylamides as potent factor Xa inhibitors. Part 3: Design, synthesis and SAR of orally bioavailable benzamidine-P4 inhibitors

ZJ Jia, Y Wu, W Huang, P Zhang, Y Song… - Bioorganic & medicinal …, 2004 - Elsevier
Using N, N-dialkylated benzamidines as the novel P4 motifs, we have designed and
synthesized a class of 1-(2-naphthyl)-1H-pyrazole-5-carboxylamides as highly potent and …

Cycloalkanediamine derivatives as novel blood coagulation factor Xa inhibitors

T Nagata, T Yoshino, N Haginoya, K Yoshikawa… - Bioorganic & medicinal …, 2007 - Elsevier
This paper describes the synthesis of orally available potent fXa inhibitors 2 and 3 by
modification of the piperazine part of lead compound 1. Carbonyl derivative 3 showed potent …

Anthranilamide-based N, N-dialkylbenzamidines as potent and orally bioavailable factor Xa inhibitors: P4 SAR

P Zhang, L Bao, J Fan, ZJ Jia, U Sinha… - Bioorganic & medicinal …, 2009 - Elsevier
Anthranilamide-based benzamidine compound 4 and its N-substituted analogs were
designed and examined as factor Xa inhibitors using substituted benzamidines as …

Synthesis and biological activity of novel 1, 2-disubstituted benzene derivatives as factor Xa inhibitors

H Koshio, F Hirayama, T Ishihara, R Shiraki… - Bioorganic & medicinal …, 2005 - Elsevier
Factor Xa (fXa) is a serine protease that plays a pivotal role in the coagulation cascade. High-
throughput screening of the Yamanouchi compound library yielded lead compound 1 with …